{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:06:55Z","timestamp":1769044015195,"version":"3.49.0"},"reference-count":8,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1080\/1042819031000079140","type":"journal-article","created":{"date-parts":[[2003,11,10]],"date-time":"2003-11-10T17:33:23Z","timestamp":1068485603000},"page":"1239-1241","source":"Crossref","is-referenced-by-count":59,"title":["Acute Renal Failure Secondary to Imatinib Mesylate Treatment in Chronic Myeloid Leukemia"],"prefix":"10.1080","volume":"44","author":[{"given":"Monica","family":"Pou","sequence":"first","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Saval","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Vera","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Saurina","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Sol\u00e9","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Cervantes","sequence":"additional","affiliation":[{"name":"Hemathology Department, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Botey","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,8,3]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"\"A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining\"","volume":"43","author":"Rowley J","year":"1973","unstructured":"Rowley, J. (1973) \"A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining\", Nature 43, 290\u2013293.","journal-title":"Nature"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"\"Induction of chronic myelogenous leukemia in mice by the P210 bcr\/abl gen of the Philadelphia chromosome\"","volume":"247","author":"Daley G.Q.","year":"1990","unstructured":"Daley, G.Q., Van Erten, R.A. and Baltimore, D. (1990) \"Induction of chronic myelogenous leukemia in mice by the P210 bcr\/abl gen of the Philadelphia chromosome\", Science 247, 824\u2013830.","journal-title":"Science"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V82.7.2235.2235","article-title":"\"Choice of pretransplant treatment and timing of transplant for chronic myelogenous leukemia in chronic phase\"","volume":"82","author":"Goldman J.","year":"1993","unstructured":"Goldman, J., Szycllo, R., Horowitz, M.M., Gale, R.P., Ash, R.C., Atkinson, K., Dicke, K.A., Gluckman, E., Herzig, R.H. and Marmont, A. (1993) \"Choice of pretransplant treatment and timing of transplant for chronic myelogenous leukemia in chronic phase\", Blood 82, 2235\u20132238.","journal-title":"Blood"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"\"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia\"","author":"Druker B.","year":"2001","unstructured":"Druker, B., Talpaz, M., Resta, D., Bin Peng, RN., Buchdunger, E., Ford, J., Lydon, N., Kantarjian, H., Capdeville, R., Ohno-Jones, S. and Sawyers, C. (2001) \"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia\", N. Engl. J. Med. 344, 1031\u20131037.","journal-title":"N. Engl. J. Med"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"\"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia\"","volume":"346","author":"Kantarjian H.","year":"2002","unstructured":"Kantarjian, H., Sawyers, C., Hochhaus, A., Guilhot, F., Schiffer, C., Gambacorti-Passerini, C., Niederwieser, D., Resta, D., Capdeville, R., Zoeliner, U., Talpaz, M. and Drucker, B. (2002) \"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia\", N. Engl. J. Med. 346, 645\u2013652.","journal-title":"N. Engl. J. Med"},{"key":"e_1_2_1_7_1","first-page":"685","article-title":"\"Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, 5TI571\"","volume":"17","author":"Kitiyakara C.","year":"2002","unstructured":"Kitiyakara, C. and Atichartakarn, V. (2002) \"Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, 5TI571\", NDT 17, 685\u2013687.","journal-title":"NDT"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"\"Effects of selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells\"","volume":"2","author":"Druker B.J.","year":"1996","unstructured":"Druker, B.J., Tamura, S., Buchdunger, E., Ohno, S., Segal, GM., Fanning, S., Zimmermann, J. and Lydon, N.B. (1996) \"Effects of selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells\", Nat. Med. 2, 561\u2013566.","journal-title":"Nat. Med"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.2001.0590041324.x","article-title":"\"PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis\"","author":"Gilbert R.E.","year":"2001","unstructured":"Gilbert, R.E., Kelly, D.J., McKay, T., Chadban, S., Hill, P.A., Cooper, ME., Atkins, R.C. and Nikolic-Paterson, D.J. (2001) \"PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis\", Kidney Int. 59, 1324\u20131332.","journal-title":"Kidney Int"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/1042819031000079140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:31:55Z","timestamp":1695285115000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/1042819031000079140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1080\/1042819031000079140"],"URL":"https:\/\/doi.org\/10.1080\/1042819031000079140","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}